EntryPoint Capital’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$327K Buy
38,545
+2,246
+6% +$14.9K 0.08% 508
2026
Q1
$198K Buy
+36,299
New +$204K 0.06% 649
2025
Q3
Sell
-17,588
Closed -$153K 869
2025
Q2
$153K Buy
+17,588
New +$127K 0.08% 532
2024
Q4
Sell
-16,452
Closed -$151K 957
2024
Q3
$151K Sell
16,452
-6,167
-27% -$51K 0.09% 514
2024
Q2
$221K Buy
22,619
+20,581
+1,010% +$251K 0.1% 348
2024
Q1
$30.8K Sell
2,038
-2,990
-59% -$54.3K 0.03% 950
2023
Q4
$108K Buy
+5,028
New +$92.8K 0.1% 344

Other funds holding TDOC

EntryPoint Capital's TDOC Position: Q2 2026 in Review

EntryPoint Capital increased its Teladoc Health (TDOC) stake by 6.2% in Q2 2026, buying an estimated $14.9K and bringing the position to 38,545 shares worth $327K. The position accounts for 0.08% of the portfolio, ranked #508.

EntryPoint Capital first reported a position in TDOC in Q4 2023 and has held it in 7 quarters since. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • EntryPoint Capital held 38,545 shares of Teladoc Health worth $327K as of Q2 2026.
  • EntryPoint Capital bought 2,246 Teladoc Health shares in Q2 2026, an estimated $14.9K.
  • Teladoc Health made up 0.08% of EntryPoint Capital's portfolio in Q2 2026, its #508 holding.
  • EntryPoint Capital first reported a position in Teladoc Health in Q4 2023 and has held it in 7 quarters since.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.